We hypothesize that the ER/PR can bind to the ERE/PRE DNA sequences in breast cancer cells and activate the expression of near-infrared fluorescent protein, providing a specific and reliable method for imaging ER/PR expression in breast cancers. This evidence concerns the gene ESR1 and breast carcinoma.